Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2017-11-07
2020-06-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acceptability of Human Papillomavirus (HPV) Self-sampling Tools for Cervical Cancer Prevention
NCT03613493
Using CHWs and HPV Home Tests to Increase Cervical Cancer Screening in Minority Populations
NCT02121548
Increasing HPV Vaccination Rates Via Educational Interventions in Schools Located Within Cedars-Sinai Catchment Areas
NCT03953911
An Intervention Study To Improve Human PapillomaVirus ( HPV) Immunization in Haitian and African American Girls
NCT01254669
Using CHWs or Mailing Self Sampling Home Tests to Increase Cervical Cancer Screening in South Florida
NCT02202109
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Twalet Deba Group
Participants will receive cervical cancer prevention education, and provide self-administered vaginal or cervical specimens and provide specimens of plants, plant-products or herbs most commonly used in the intravaginal cleansing practice of twalet deba. Total expected participation is about 30 days.
Cervical Cancer Prevention Education
Participants will receive in-person, one-time health education on the importance of cervical cancer screening using a short intervention/educational script; and motivation to encourage women to have human papillomavirus (HPV) screening. Participants will also be informed of the nature and risks of HPV infection, and the importance of seeing a doctor including having a gynecologic exam.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cervical Cancer Prevention Education
Participants will receive in-person, one-time health education on the importance of cervical cancer screening using a short intervention/educational script; and motivation to encourage women to have human papillomavirus (HPV) screening. Participants will also be informed of the nature and risks of HPV infection, and the importance of seeing a doctor including having a gynecologic exam.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Self-identifies as Haitian or Haitian-American
* Resident of Miami-Dade, Broward or Palm Beach County
* Currently engages in regular intravaginal cleansing practices that involve more than just water alone
* No history of hysterectomy
* Speaks Creole or English
Exclusion Criteria
* Individuals less than 18 years of age
* Pregnant women
* Prisoners
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cigna Foundation
UNKNOWN
University of Miami
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Erin Kobetz-Kerman, PhD, MPH
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Erin Kobetz-Kerman, PhD, MPH
Role: PRINCIPAL_INVESTIGATOR
University of Miami
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Martine Poitevien
Miami, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2023-00177
Identifier Type: REGISTRY
Identifier Source: secondary_id
20170445
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.